Latest Hologic Stories
BEDFORD, Mass., Jan. 3, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that it has entered into a definitive agreement to sell its LIFECODES business unit to Immucor, Inc. Under the terms of the agreement, Hologic will receive $85 million in cash at closing, subject to...
ST. LOUIS, Dec. 28, 2012 /PRNewswire/ -- K-V Pharmaceutical Company ("K-V" or "the Company") today announced that the U. S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, approved the Company's settlement agreement with Hologic, Inc. ("Hologic Settlement"), and authorized the Company to enter into an $85 million debtor-in-possession ("DIP") financing to, among other things, fund the settlement. "The resolution of the...
ST. LOUIS, Dec. 12, 2012 /PRNewswire/ -- K-V Pharmaceutical Company ("K-V" or "the Company") today announced that it has received a commitment from lenders led by an affiliate of Silver Point Finance LLC for $85 million in senior secured post-petition debtor-in-possession ("DIP") financing, which the Company intends to use to, among other things, satisfy the terms of its recently filed settlement agreement with Hologic, Inc. ("Hologic Settlement"), provide additional financial...
MPLN converting HPV Testing to Hologic/Gen-Probe APTIMA ASSAY. Maryville, TN (PRWEB) December 06, 2012 MPLN announced today that they will be adopting the Hologic/Gen-Probe APTIMA Human papillomavirus (HPV) assay effective January 2, 2013. This assay will be run on the fully automated high throughput TIGRIS DTS System. “Our goal at MPLN is to offer our clients the most comprehensive experience in molecular diagnostics, and we believe the new Hologic/Gen-Probe APTIMA HPV assay is a...
Two seasoned business leaders join the Board QUEBEC CITY, Nov. 26, 2012 /PRNewswire/ - DiagnoCure Inc. (TSX: CUR) today announced that its Board of Directors has appointed two new members, effective immediately. The new directors are Dr. Jacques Simoneau, current President and Chief Executive Officer of Gestion Univalor L.P. and Mr. Andrew J. Sheldon, current President and Chief Executive Officer of Medicago. The two new directors will also stand for re-election at DiagnoCure's...
BEDFORD, Mass., Nov. 19, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will feature its newest women's health products at the 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place in Chicago, November 25 through...
BEDFORD, Mass., Nov. 9, 2012 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that Glenn Muir, Executive Vice President and Chief Financial Officer, will present at the following upcoming investor conferences: Lazard Capital Markets 9(th) Annual Healthcare Conference in New York City on Wednesday, November 14, 2012 at 8:30 a.m. Eastern Time. NASDAQ OMX 29(th) Investor Program in London, England on Tuesday, December 4, 2012 at 10:15 am Greenwich Mean Time (5:15 a.m....
BEDFORD, Mass., Nov. 5, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that its suite of gynecologic surgical products will be on display at the 41(st) AAGL Global Congress on Minimally Invasive Gynecology, November 5-9, 2012, in Las Vegas, NV. The American Association of...
BEDFORD, Mass., Oct. 16, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's APTIMA HPV 16 18/45 Genotype Assay for use on its TIGRIS instrument system. Hologic's APTIMA HPV 16 18/45 Genotype Assay is...
BEDFORD, Mass., Oct. 4, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced a favorable ruling in its patent infringement litigation filed by its subsidiary, Gen-Probe (formerly Gen-Probe Incorporated), against Becton, Dickinson and Company (BD) (NYSE: BDX). In a decision dated...
